Back to all people

Chenguang Wang

Regeneron Pharmaceuticals, Inc.

5 appearances in the program

Sessions & presentations

PS21: From Dose Selection to Adaptation: Recent Innovations in Oncology Trials

Parallel · Thu, Sep 25 , 4:15 PM

Organizer

PS13: Optimizing Safety Data Practices for Clinical Trials: Insights from the C3TI SSDC Program

Parallel · Thu, Sep 25 , 2:45 PM

Co-Organizer

PS23: Advancing Medicine Development Through the Synergy of Quantitative Science Disciplines

Parallel · Thu, Sep 25 , 4:15 PM

Co-Organizer

PS29: Borrowing External Data in Rare Disease Trials: Methods, Applications, and Beyond

Parallel · Fri, Sep 26 , 8:30 AM

Discussant

PS29: Borrowing External Data in Rare Disease Trials: Methods, Applications, and Beyond

Parallel · Fri, Sep 26 , 8:30 AM

Chair

↑